News

Circassia floored by trial failure

Country
United Kingdom

The share price of Circassia Pharmaceuticals Plc fell by 64.85% to 95 pence in mid-morning trading on 20 June following the announcement that its phase-3 trial of its cat allergy drug failed to meet its primary endpoint.

Woodford investment in Imperial cleared

Country
United Kingdom

Woodford Investment Management LLP has raised its stake in Imperial Innovations Group to 21% making it the group’s second most significant investor behind Invesco Asset Management.

Mainstay raises €30 million with shares

Country
Ireland

Medical device company Mainstay Medical International Plc has raised €30 million in a share placement to new and existing investors to commercialise its implantable neurostimulation device for back pain in Europe and complete a trial for a US regulatory submission.

Medivir investigates corporate split

Country
Sweden

Sweden-based Medivir AB has engaged professional advisors to investigate the possibility of reorganising the company into two independent businesses in order to deliver more value to shareholders. The announcement was made to the Nasdaq Stockholm stock exchange on 15 June.

Allecra raises €22 million to develop antibiotic

Country
Germany

Allecra Therapeutics, a three-year old biotech company co-located in Germany and France, has raised €22 million in a Series B investment round to finance the development of an antibiotic combination therapy designed to treat Gram-negative bacteria.

Gilde Healthcare raises €250 million for new fund

Country
Netherlands

Gilde Healthcare Partners BV has raised €250 million for its fourth life science fund that targets investments in medical devices, digital health technology and therapeutics in Europe and North America. Koninklijke Philips NV acted as a cornerstone investor.

Kite therapy gets EMA designation

Country
United Kingdom

The European Medicines Agency has agreed to give an accelerated review of a gene therapy being developed by Kite Pharma Inc that promises to improve the standard of care for patients with diffuse large B-cell lymphoma (DLBCL), a type of blood cancer.

Study shows promise of stem cells for osteoarthritis

Country
France

A Phase 1 study of 18 patients with severe osteoarthritis of the knee has shown that a single injection of stem cells derived from the patients’ own adipose tissue was safe and appeared to offer relief from pain.